420 with CNW - Large Trial Shows Marijuana Treats Chronic Back Pain

2025-10-02 16:25:00 ET

According to the World Health Organization (WHO), lower back pain affects more than 500 million individuals worldwide and is one of the primary causes of disability . Treatment options, however, remain limited, with most patients relying on common painkillers or opioids, which carry a high risk of dependence and addiction.

These clinical trial results are likely to provide additional credence to the conviction of companies like Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) about the…

Read More>>

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

News Provided by CannabisNewsWire via QuoteMedia

ACB:CC
The Conversation (0)

Aurora Cannabis Provides Business Update and Announces Date of Third Quarter Fiscal Year 2024 Investor Conference Call

NASDAQ | TSX: ACB Re-affirms expectation of positive annual Adjusted EBITDA 1 for fiscal 2024 and Positive Free Cash Flow 1 generation in calendar 2024 Announces Intention to Consolidate Common Shares Q3 2024 Investor Conference call scheduled for February 8, 2024 at 8:00 a.m. Eastern Time... Keep Reading...

Aurora Unveils Innovative Cannabis-Infused Ready-to-Drink Beverage in Latest Medical Product Launch

NASDAQ | TSX: ACB Available at launch exclusively to Aurora's veteran patients, new products span THC, CBD and CBG offerings to meet the discerning taste, experience and product variety patients seek Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical... Keep Reading...

Aurora Cannabis Announces Fiscal 2024 Second Quarter Results and Delivers Record Positive Adjusted EBITDA

NASDAQ | TSX: ACB Delivers Record Positive Adjusted EBITDA 1 of $ 3.4 Million Quarterly Net Revenue 1 rose 30% YoY to $63.4 Million ; Strong Growth of 42 % in Global Medical Cannabis Net cash position of over $200 Million , Expects to Repay the Remaining US$5.3 Million Balance of Convertible... Keep Reading...

Aurora Cannabis to Host Second Quarter Fiscal Year 2024 Investor Conference Call

NASDAQ | TSX: ACB Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, announced today that it has scheduled a conference call to discuss the results for its second quarter fiscal year 2024 on Thursday, November 9, 2023 at... Keep Reading...

Aurora Cannabis Announces Settlement of Patent Litigation

NASDAQ | TSX: ACB Company affirms commitment to enforce and defend intellectual property rights Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, today announced the company and WILLOW BIOSCIENCES, INC. ("Willow") have successfully completed a... Keep Reading...

Latest Press Releases

Related News